investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Using Clinical Pharmacology Principles to Develop New Anticancer Therapies

William Figg

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Related projects

Carl F Ware

HVEM-BTLA Pathway in Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Richard A Flavell

Understanding Hemotopoietic Neoplasias using Humanized Mice

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Elad Ziv

Influence of germ line genetic variation on myeloma progression and survival

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

David L Woodland

Immune Evolution in Cancer

Multiple myeloma and immunoproliferative diseases Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Satish Gopal

Molecular profiling of HIV-associated lymphoma in the US and Malawi

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Shao-Cong Sun

Oncogenic Activation of Noncanonical NF-kB in B-cell Lymphomas

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

John Nicholas

BH3-only Protein Targeting by HHV-8

Non-Hodgkin lymphoma

Pathology

Hui-Kuan Lin

The Crosstalk Between the PI3K/Akt signal and Skp2 in Prostate Cancer Progression

Prostate

Pathology